Sigma Healthcare Past Earnings Performance
Past criteria checks 0/6
Sigma Healthcare's earnings have been declining at an average annual rate of -10.1%, while the Healthcare industry saw earnings declining at 3.3% annually. Revenues have been growing at an average rate of 0.5% per year.
Key information
-10.1%
Earnings growth rate
-7.2%
EPS growth rate
| Healthcare Industry Growth | 2.4% |
| Revenue growth rate | 0.5% |
| Return on equity | -0.3% |
| Net Margin | -0.09% |
| Last Earnings Update | 31 Jul 2024 |
Recent past performance updates
Recent updates
Sigma Healthcare Limited's (ASX:SIG) Subdued P/S Might Signal An Opportunity
Feb 24
Is There An Opportunity With Sigma Healthcare Limited's (ASX:SIG) 49% Undervaluation?
Jan 05Sigma Healthcare (ASX:SIG) Will Pay A Dividend Of AU$0.01
Mar 31Some Investors May Be Worried About Sigma Healthcare's (ASX:SIG) Returns On Capital
Dec 08The Returns On Capital At Sigma Healthcare (ASX:SIG) Don't Inspire Confidence
May 11Shareholders Shouldn’t Be Too Comfortable With Sigma Healthcare's (ASX:SIG) Strong Earnings
Mar 29Sigma Healthcare Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Mar 24How Many Sigma Healthcare Limited (ASX:SIG) Shares Do Institutions Own?
Feb 16We Think Sigma Healthcare (ASX:SIG) Has A Fair Chunk Of Debt
Jan 19What Type Of Returns Would Sigma Healthcare's(ASX:SIG) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Dec 31Are Insiders Buying Sigma Healthcare Limited (ASX:SIG) Stock?
Dec 13Revenue & Expenses Breakdown
How Sigma Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jul 24 | 3,481 | -3 | 267 | 0 |
| 30 Apr 24 | 3,401 | 1 | 260 | 0 |
| 31 Jan 24 | 3,322 | 5 | 254 | 0 |
| 31 Oct 23 | 3,414 | 10 | 263 | 0 |
| 31 Jul 23 | 3,506 | 15 | 271 | 0 |
| 30 Apr 23 | 3,583 | 8 | 282 | 0 |
| 31 Jan 23 | 3,660 | 2 | 293 | 0 |
| 31 Oct 22 | 3,605 | -3 | 300 | 0 |
| 31 Jul 22 | 3,550 | -7 | 308 | 0 |
| 30 Apr 22 | 3,498 | -7 | 309 | 0 |
| 31 Jan 22 | 3,446 | -7 | 310 | 0 |
| 31 Oct 21 | 3,469 | 20 | 304 | 0 |
| 31 Jul 21 | 3,491 | 47 | 298 | 0 |
| 30 Apr 21 | 3,446 | 45 | 303 | 0 |
| 31 Jan 21 | 3,400 | 44 | 309 | 0 |
| 31 Oct 20 | 3,205 | 12 | 306 | 0 |
| 31 Jul 20 | 3,009 | -19 | 302 | 0 |
| 30 Apr 20 | 3,127 | -16 | 296 | 0 |
| 31 Jan 20 | 3,244 | -12 | 289 | 0 |
| 31 Oct 19 | 3,570 | 7 | 290 | 0 |
| 31 Jul 19 | 3,897 | 26 | 292 | 0 |
| 30 Apr 19 | 3,937 | 31 | 294 | 0 |
| 31 Jan 19 | 3,977 | 37 | 296 | 0 |
| 31 Oct 18 | 4,015 | 39 | 295 | 0 |
| 31 Jul 18 | 4,054 | 41 | 293 | 0 |
| 30 Apr 18 | 4,074 | 48 | 284 | 0 |
| 31 Jan 18 | 4,094 | 55 | 275 | 0 |
| 31 Oct 17 | 4,156 | 56 | 269 | 0 |
| 31 Jul 17 | 4,218 | 57 | 264 | 0 |
| 30 Apr 17 | 4,292 | 55 | 261 | 0 |
| 31 Jan 17 | 4,366 | 53 | 258 | 0 |
| 31 Oct 16 | 4,149 | 54 | 254 | 0 |
| 31 Jul 16 | 3,932 | 55 | 251 | 0 |
| 30 Apr 16 | 3,697 | 53 | 244 | 0 |
| 31 Jan 16 | 3,461 | 51 | 236 | 0 |
| 31 Oct 15 | 3,388 | 50 | 227 | 0 |
| 31 Jul 15 | 3,315 | 49 | 219 | 0 |
| 30 Apr 15 | 3,229 | 51 | 210 | 0 |
| 31 Jan 15 | 3,142 | 53 | 201 | 0 |
| 31 Oct 14 | 3,077 | 56 | 192 | 0 |
| 31 Jul 14 | 3,012 | 60 | 182 | 0 |
| 30 Apr 14 | 2,993 | 57 | 181 | 0 |
| 31 Jan 14 | 2,973 | 54 | 180 | 0 |
| 31 Oct 13 | 2,980 | 31 | 179 | 0 |
Quality Earnings: SIG is currently unprofitable.
Growing Profit Margin: SIG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SIG is unprofitable, and losses have increased over the past 5 years at a rate of 10.1% per year.
Accelerating Growth: Unable to compare SIG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SIG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-25.4%).
Return on Equity
High ROE: SIG has a negative Return on Equity (-0.25%), as it is currently unprofitable.